CATALYST PHARMACEUTICALS INC. - COMMON STOCK

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan

24 9 2024 06:00:27 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

20 9 2024 09:45:04 提供 NetDania Notify

NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

19 9 2024 09:45:06 提供 NetDania Notify

NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

22 8 2024 16:05:07 提供 NetDania Notify

NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

21 8 2024 09:45:02 提供 NetDania Notify

NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

20 8 2024 10:35:11 提供 NetDania Notify

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

20 8 2024 08:03:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

19 8 2024 10:26:35 提供 NetDania Notify

NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

16 8 2024 10:11:28 提供 NetDania Notify

NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

15 8 2024 14:15:01 提供 NetDania Notify

NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

13 8 2024 09:45:04 提供 NetDania Notify

NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

12 8 2024 15:05:33 提供 NetDania Notify

NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

09 8 2024 10:22:00 提供 NetDania Notify

NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

08 8 2024 12:28:33 提供 NetDania Notify

Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update

07 8 2024 16:11:34 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

24 7 2024 09:55:10 提供 NetDania Notify

Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE® in Canada

24 7 2024 08:05:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

23 7 2024 10:55:07 提供 NetDania Notify

Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024

22 7 2024 08:03:00 提供 Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®

30 5 2024 13:41:21 提供 Nasdaq GlobeNewswire